Immunogenicity of COVID-19 vaccines in patients with follicular lymphoma receiving frontline chemo-immunotherapy. Â
Plain English Summary of the Publication:
Immunogenicity of COVID-19 vaccines in patients with follicular lymphoma receiving frontline chemo-immunotherapy.
Webinar: Cutting-Edge Treatments for FL: What’s New and What’s NextÂ
This session brings together leading experts and a patient who has experienced CAR-T therapy to provide a comprehensive look at emerging therapies for FL, including CAR-T, bispecific antibodies, BTK inhibitors, and more.
Andrew’s story
I was diagnosed with stage 4 follicular lymphoma at 25 years old. Before my cancer diagnosis I was in my mid-twenties and life was very exciting. The moment I found out I had cancer, is one that I’ll never forget.
Exploring the Future of Chemotherapy with Professor Jessica Okosun Â
Professor Jessica Okosun, FLF Scientific Advisor, answers your questions on chemotherapy-free options
Patient Survey Insights – Exploring FL Patient Experiences with Immunotherapy and Communication Preferences Â
Global patient survey results reveal key insights into patient perspectives on immunotherapy and information preferences
Mid-Year Update on Follicular Lymphoma Pathways for Clinical and Translational Investigations
We are pleased to announce the publication of our latest update, “Follicular Lymphoma: Mid-year Update on Pathways for Clinical and Translational Investigations.
Laurilyn’s story
My name is Laurilyn, and I am from the USA. I am married and a mom to two kids and am now retired.
Blood Cancer Awareness Month – you can make a difference
Every 3 minutes, someone in the U.S. is diagnosed with blood cancer. Blood Cancer Awareness Month highlights leukemia, lymphoma, and myeloma.
Anne and Stewart’s fundraising story
Anne and Stewart recently completed an incredible 432-mile cycling journey in Scotland, raising over £2000 for the FLF.
Webinar: Understanding Follicular Lymphoma Clinical Trials
View our webinar focused on sharing experiences and improving understanding of clinical trials.